Allergan reaffirms support for International Headache Academy course

Allergan has announced its continued support of the International Headache Academy, the educational scheme it has sponsored since 2013.

The programme offers a three-day intensive overview on research and treatment options for young neurologists and research scientists working in the field of headache disorder science.

The most recent event was held in Los Angeles and offered a highly interactive educational programme that encompassed future research priorities, the validation of potential drug targets, emerging new treatments, and the importance of patient advocacy.

This is the fourth year that Allergan has been the sole sponsor since the inception of the scheme in North America, while it has also supported the equivalent iHEAD scheme in Europe since 2014.

David Nicholson, chief research and development officer at Allergan, said: "The more knowledge and support neurologists have, the better equipped they will be to help patients make critical decisions about their health."

Allergan is a leader in the chronic migraine space and has offered Botox as a preventive treatment for adult chronic migraine for a number of years.

With over 20 years of experience within the pharmaceutical market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current pharmaceutical roles we have available, you can search for the latest job roles, register your details, or contact the team today.